AbbVie, BI settle IP litigation surrounding BI's Cyltezo, a Humira biosimilar
- Large Molecule
- Generic Drugs
- Includes Royalty or Profit Split Information
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.